Examples include the combined loss of chromosome 1p/19q as an essential diagnostic criterion for IDH-mutant oligodendroglioma, or homozygous deletions of CDKN2A/B as a grading criterion for IDH-mutant astrocytoma (WHO Classification of Tumours Editorial Board 2021). Here, CDKN2A is linked to astrocytoma (excluding glioblastoma).